mechlorethamine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

mechlorethamine has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagot, M; Bernard, P; Beylot-Barry, M; Cordel, N; Courville, P; D'Incan, M; de Quatrebarbes, J; Delaunay, M; Estève, E; Joly, P; Souteyrand, P; Vaillant, L1

Trials

1 trial(s) available for mechlorethamine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    Archives of dermatology, 2005, Volume: 141, Issue:9

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Beclomethasone; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Mechlorethamine; Middle Aged; Mycosis Fungoides; Skin Neoplasms

2005